Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Life Biologics is a regenerative medicine company specializing in the development and distribution of amniotic tissue-based products for clinical use. The company's portfolio includes dehydrated and cryopreserved amniotic membrane and fluid allografts designed to facilitate healing in wound care, orthopedics, and surgical applications. Their flagship products, such as LifeGraft and LifeFlow, leverage the natural anti-inflammatory and pro-healing properties of birth tissues to treat chronic wounds and soft tissue injuries. Life Biologics operates as a provider of advanced biologics, focusing on enhancing patient outcomes through minimally invasive regenerative solutions. The company emphasizes ethical sourcing and rigorous processing standards to ensure the safety and efficacy of its tissue-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Life Biologics.